Why the study?
Does the METS-IR score predict visceral adiposity and incident type 2 diabetes in healthy and at-risk subjects?
Population
Healthy and at-risk subjects
Authors
Loading...
May inform insulin resistance screening in at-risk adults; leaves open utility versus established markers pending validation.
Does the METS-IR score predict visceral adiposity and incident type 2 diabetes in healthy and at-risk subjects?
METS-IR is a novel score that predicts visceral adiposity and incident type 2 diabetes, serving as a promising tool for insulin sensitivity screening.
Bello‐Chavolla et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: